아시아태평양의 조영제 및 인젝터 시스템 시장 : 분석 및 예측(2022-2026년)

“The Asia-Pacific Contrast Media Agent and Injector System Market Expected to Reach $2.62 Billion by 2026.”

Introduction to Asia-Pacific Contrast Media Agent and Injector System Market

The Asia-Pacific contrast media agent and injector system market was valued at $1.98 billion in 2022 and is expected to reach $2.62 billion by 2026, growing at a CAGR of 7.24% during the forecast period 2022-2026.The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.

Market Introduction

The APAC Contrast Media Agent and Injector System Market is witnessing substantial growth driven by several key factors. Firstly, the rising incidence of medical conditions such as cancer and cardiovascular diseases has led to an increased demand for imaging procedures that require contrast media agents and injector systems. This is particularly crucial for accurate diagnosis and treatment planning.

Secondly, advancements in medical imaging technologies have further fueled market growth. The development of innovative contrast media agents and injector systems has improved the precision and effectiveness of diagnostic procedures, making them more accessible and reliable for healthcare providers.

Lastly, the expanding healthcare infrastructure and increasing healthcare expenditure in the Asia-Pacific region have contributed to the market's expansion. As healthcare facilities continue to modernize and upgrade their imaging capabilities, the demand for contrast media agents and injector systems is expected to continue its upward trajectory in the region.

Market Segmentation:

Segmentation 1: by Product

• Contrast Media Agents
• Injector Systems

Segmentation: Injector Systems (by Product)

• Injector
• Consumables and Accessories

Segmentation 2: by Country

• China
• Japan
• India
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.

Competitive Strategy: The APAC contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.

Key Companies Profiled

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1. Markets

• 1.1. Market Outlook
  • 1.1.1. Product Definition
  • 1.1.2. Inclusion and Exclusion Criteria
• 1.2. Market Overview
• 1.3. Industry Outlook
  • 1.3.1. Regulatory and Legal Requirements and Framework
    • 1.3.1.1. Regulatory and Legal Requirements and Framework in Asia-Pacific
      • 1.3.1.1.1. China
      • 1.3.1.1.2. Japan
  • 1.3.2. Patent Analysis
    • 1.3.2.1. Patent Filing Trend (by Year)
    • 1.3.2.2. Patent Filing Trend (by Country)
  • 1.3.3. Key Trends
    • 1.3.3.1. Nanoparticle-Based Contrast Agents
    • 1.3.3.2. Development of Safer Contrast Media Agent
    • 1.3.3.3. Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
• 1.4. Impact of COVID-19 on Contrast Media Agent and Injector System Market
  • 1.4.1. Pre-COVID-19 Impact
  • 1.4.2. During COVID-19 Impact
  • 1.4.3. Post-COVID-19 Impact
• 1.5. Market Dynamics
  • 1.5.1. Impact Analysis
  • 1.5.2. Market Drivers
    • 1.5.2.1. Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
    • 1.5.2.2. Upsurge in Demand for Image-Guided Diagnostics
    • 1.5.2.3. Growing Number of Regulatory Approvals
  • 1.5.3. Market Restraints
    • 1.5.3.1. Rising Health Concerns Post Usage of Contrast Media Agents in Body
  • 1.5.4. Market Opportunities
    • 1.5.4.1. IT Advances in Contrast Media Injectors

2. Region

• 2.1. Overview
• 2.2. Asia-Pacific
  • 2.2.1. Key Findings
  • 2.2.2. Market Dynamics
    • 2.2.2.1. Impact Analysis
  • 2.2.3. Market Size and Forecast
    • 2.2.3.1. Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
      • 2.2.3.1.1. Asia-Pacific Contrast Media Injector System Market (by Product)
    • 2.2.3.2. Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
      • 2.2.3.2.1. China
        • 2.2.3.2.1.1. Market Sizing and Forecast
        • 2.2.3.2.1.1.1. China Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.1.1.1.1. China Contrast Media Injector System Market (by Product)
      • 2.2.3.2.2. Japan
        • 2.2.3.2.2.1. Market Sizing and Forecast
        • 2.2.3.2.2.1.1. Japan Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.2.1.1.1. Japan Contrast Media Injector System Market (by Product)
      • 2.2.3.2.3. India
        • 2.2.3.2.3.1. Market Sizing and Forecast
        • 2.2.3.2.3.1.1. India Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.3.1.1.1. India Contrast Media Injector System Market (by Product)
      • 2.2.3.2.4. Australia
        • 2.2.3.2.4.1. Market Sizing and Forecast
        • 2.2.3.2.4.1.1. Australia Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.4.1.1.1. Australia Contrast Media Injector System Market (by Product)
      • 2.2.3.2.5. Rest-of-Asia-Pacific
        • 2.2.3.2.5.1. Market Sizing and Forecast
        • 2.2.3.2.5.1.1. Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.2.5.1.1.1. Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)

3. Markets - Competitive Benchmarking & Company Profiles

• 3.1. Competitive Benchmarking
  • 3.1.1. Key Strategies and Development
    • 3.1.1.1. Regulatory and Legal Activities
    • 3.1.1.2. Partnerships, Collaborations, and Business Expansions
    • 3.1.1.3. Mergers and Acquisitions
    • 3.1.1.4. New Offerings
  • 3.1.2. Market Share Analysis
    • 3.1.2.1. Market Share Analysis, by Contrast Media Agent Market
    • 3.1.2.2. Market Share Analysis, by Contrast Media Injector System Market
• 3.2. Contrast Media Ecosystem Active Players
• 3.3. Company Profiles
  • 3.3.1. Beijing Beilu Pharmaceutical Co. Ltd.
    • 3.3.1.1. Company Overview
    • 3.3.1.2. Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Contrast Media Agent and Injector System Market
    • 3.3.1.3. Recent Developments
    • 3.3.1.4. Analyst Perception
  • 3.3.2. FUJIFILM Holdings Corporation
    • 3.3.2.1. Company Overview
    • 3.3.2.2. Role of FUJIFILM Holdings Corporation in the Contrast Media Agent and Injector System Market
    • 3.3.2.3. Financials
    • 3.3.2.4. Analyst Perception
  • 3.3.3. Jiangsu Hengrui Pharmaceutical Co., Ltd.
    • 3.3.3.1. Company Overview
    • 3.3.3.2. Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Contrast Media Agent and Injector System Market
    • 3.3.3.3. Recent Developments
    • 3.3.3.4. Analyst Perception
  • 3.3.4. Jodas Expoim Pvt. Ltd.
    • 3.3.4.1. Company Overview
    • 3.3.4.2. Role of Jodas Expoim Pvt. Ltd. in the Contrast Media Agent and Injector System Market
    • 3.3.4.3. Analyst Perception
  • 3.3.5. Shenzen Seacrown Electromechanical Co., Ltd.
    • 3.3.5.1. Company Overview
    • 3.3.5.2. Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Contrast Media Agent and Injector System Market
    • 3.3.5.3. Recent Developments
    • 3.3.5.4. Analyst Perception
  • 3.3.6. Sino Medical-Device Technology Co., Ltd.
    • 3.3.6.1. Company Overview
    • 3.3.6.2. Role of Sino Medical-Device Technology Co., Ltd. in the Contrast Media Agent and Injector System Market
    • 3.3.6.3. Analyst Perception
  • 3.3.7. Unijules Life Sciences Ltd.
    • 3.3.7.1. Company Overview
    • 3.3.7.2. Role of Unijules Life Sciences Ltd. in the Contrast Media Agent and Injector System Market
    • 3.3.7.3. Analyst Perception